Myelodysplastic syndrome causes: Difference between revisions
Nawal Muazam (talk | contribs) No edit summary |
Nawal Muazam (talk | contribs) No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}};{{AE}} {{NM}} | {{CMG}};{{AE}} {{NM}} | ||
==Overview== | ==Overview== | ||
Common causes of secondary myelodysplastic syndrome include radiation, | The cause of primary myelodysplastic syndrome has not been identified.<ref name=cancergov2>Risk factors of myelodysplastic syndrome. National Cancer Institute (2015). http://www.cancer.gov/types/myeloproliferative/hp/myelodysplastic-treatment-pdq/#link/_204_toc. Accessed on December 9, 2015</ref> Common causes of secondary myelodysplastic syndrome include [[radiation]], [[busulfan]], [[nitrosourea]], [[procarbazine]], [[Topoisomerase inhibitor|DNA topoisomerase inhibitors]], [[Aplastic anemia|acquired aplastic anemia]], and [[Fanconi's anemia ]].<ref name=cancergov2>Risk factors of myelodysplastic syndrome. National Cancer Institute (2015). http://www.cancer.gov/types/myeloproliferative/hp/myelodysplastic-treatment-pdq/#link/_204_toc. Accessed on December 9, 2015</ref> | ||
==Causes== | ==Causes== | ||
===Primary Myelodysplastic syndrome=== | ===Primary Myelodysplastic syndrome=== | ||
| Line 9: | Line 9: | ||
===Secondary Myelodysplastic syndrome=== | ===Secondary Myelodysplastic syndrome=== | ||
Common causes of secondary myelodysplastic syndrome include:<ref name=cancergov2>Risk factors of myelodysplastic syndrome. National Cancer Institute (2015). http://www.cancer.gov/types/myeloproliferative/hp/myelodysplastic-treatment-pdq/#link/_204_toc. Accessed on December 9, 2015</ref> | Common causes of secondary myelodysplastic syndrome include:<ref name=cancergov2>Risk factors of myelodysplastic syndrome. National Cancer Institute (2015). http://www.cancer.gov/types/myeloproliferative/hp/myelodysplastic-treatment-pdq/#link/_204_toc. Accessed on December 9, 2015</ref> | ||
*Radiation | *[[Radiation]] | ||
*Benzene | *[[Benzene]] | ||
*Busulfan | *[[Busulfan]] | ||
*Nitrosourea | *[[Nitrosourea]] | ||
*Procarbazine | *[[Procarbazine]] | ||
*DNA topoisomerase inhibitors | *[[Topoisomerase inhibitor|DNA topoisomerase inhibitors]] | ||
*Acquired aplastic anemia | *[[Aplastic anemia|Acquired aplastic anemia]] | ||
*Fanconi's anemia | *[[Fanconi's anemia ]] | ||
==References== | ==References== | ||
{{Reflist|1}} | {{Reflist|1}} | ||
Revision as of 23:08, 13 December 2015
|
Myelodysplastic syndrome Microchapters |
|
Differentiating Myelodysplastic syndrome from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Myelodysplastic syndrome causes On the Web |
|
American Roentgen Ray Society Images of Myelodysplastic syndrome causes |
|
Risk calculators and risk factors for Myelodysplastic syndrome causes |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Nawal Muazam M.D.[2]
Overview
The cause of primary myelodysplastic syndrome has not been identified.[1] Common causes of secondary myelodysplastic syndrome include radiation, busulfan, nitrosourea, procarbazine, DNA topoisomerase inhibitors, acquired aplastic anemia, and Fanconi's anemia .[1]
Causes
Primary Myelodysplastic syndrome
Approximately 90% of MDS cases occur de novo with no identifiable cause.[1]
Secondary Myelodysplastic syndrome
Common causes of secondary myelodysplastic syndrome include:[1]
- Radiation
- Benzene
- Busulfan
- Nitrosourea
- Procarbazine
- DNA topoisomerase inhibitors
- Acquired aplastic anemia
- Fanconi's anemia
References
- ↑ 1.0 1.1 1.2 1.3 Risk factors of myelodysplastic syndrome. National Cancer Institute (2015). http://www.cancer.gov/types/myeloproliferative/hp/myelodysplastic-treatment-pdq/#link/_204_toc. Accessed on December 9, 2015